Healthcare ❯ Medical Devices

Regulatory Compliance

FDA Regulations False Claims Act South African Health Products Regulatory Authority Market Competition Misbranding Corporate Governance Financial Obligations FDA Approval Process Product Development

DexCom Investors Face Late-December Deadlines in Suits Over FDA-Flagged CGM Changes

Investor law firms set late-December deadlines tied to suits referencing an FDA warning over unauthorized CGM sensor changes.

Exactech to Pay $8 Million After Court Approves False Claims Act Settlement